Offer - Urjas Oil for just ₹ 1 X
Depramine 75 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Obsessive Compulsive Disorder.
The correct dosage of Depramine 75 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Depramine 75 Tablet can also lead to other problems, which have been listed below. Such side effects of Depramine 75 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Depramine 75 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. Warnings related to Depramine 75 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Depramine 75 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Depramine 75 Tablet in conditions like Heart Disease, Coronary Artery Disease (CAD), Suicidal Tendency. Some other conditions that can be affected by Depramine 75 Tablet are listed in the contraindications section below.
Drug reaction of Depramine 75 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Depramine 75 Tablet is not safe while driving, and is not addiction.
Depramine 75 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Depramine 75 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Depramine. It is best to stop taking Depramine immediately and inform your doctor if you notice any discomfort.
Is the use of Depramine 75 Tablet safe during breastfeeding?
Taking Depramine may lead to serious side effects if you are breastfeeding. Depramine should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Depramine 75 Tablet on the Kidneys?
Depramine is completely safe for kidneys.
What is the effect of Depramine 75 Tablet on the Liver?
Depramine has very mild side effects on the liver.
What is the effect of Depramine 75 Tablet on the Heart?
Depramine has very mild side effects on the heart.
Depramine 75 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Depramine 75 Tablet unless your doctor advises you to do so -
Is this Depramine 75 Tablet habit forming or addictive?
Depramine 75 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Depramine 75 Tablet. So it is best to avoid driving.
Is it safe?
Depramine 75 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, Depramine 75 Tablet is useful in treating mental disorders.
Interaction between Food and Depramine 75 Tablet
Taking Depramine 75 Tablet with food does not harm your health.
Interaction between Alcohol and Depramine 75 Tablet
Consult your doctor before consuming alcohol while taking Depramine 75 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Anafranil® (clomipramine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454, 456, 458, 464